PET Imaging of HER2-Positive Tumors with Cu-64-Labeled Affibody Molecules

被引：0
|
作者：
Shibo Qi
Susan Hoppmann
Yingding Xu
Zhen Cheng
机构：
[1] Tianjin Polytechnic University,School of Environmental and Chemical Engineering
[2] Stanford University,Molecular Imaging Program at Stanford (MIPS), Department of Radiology, and Bio
来源：
Molecular Imaging and Biology | 2019年 / 21卷
关键词：
PET; Affibody; HER2; Cu-64; Tumor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：907 / 916
页数：9
相关论文
共 50 条
  • [31] Functional imaging of HER2-positive metastatic breast cancer using 64Cu DOTA-trastuzumab positron emission tomography (PET)
    Mortimer, Joanne E.
    Conti, Peter
    Tong, Shan
    Reyes, Jose
    Carroll, Mary I.
    Poku, Kofi
    Colcher, David
    Raubitschek, Andrew Antony
    Bading, James R.
    Miles, Joshua
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [32] PET targeting molecular maging of human epidermal growth factor receptor-positive tumors labeled with Affibody molecules
    Sun, Xilin
    Chen, Weizhi
    Zhao, Changjiu
    Wang, Kai
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [33] Optimizing radiocobalt labeled HER3-targeting affibody molecules for next day PET-imaging of HER3 expression
    Rinne, Sara
    Leitao, Charles Dahlsson
    Mitran, Bogdan
    Tolmachev, Vladimir
    Stahl, Stefan
    Lofblom, John
    Orlova, Anna
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [34] Cu-64-Labeled geldanamycin derivative for imaging HSP90 expression in breast cancer
    Li, Feng
    McHann, Melissa
    Chen, Jiexiao
    Yang, Zhen
    Furenlid, Lars
    Martin, Diego
    Liu, Zhonglin
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [35] PET/CT and SPECT/CT Imaging of HER2-Positive Breast Cancer
    McGale, Jeremy
    Khurana, Sakshi
    Huang, Alice
    Roa, Tina
    Yeh, Randy
    Shirini, Dorsa
    Doshi, Parth
    Nakhla, Abanoub
    Bebawy, Maria
    Khalil, David
    Lotfalla, Andrew
    Higgins, Hayley
    Gulati, Amit
    Girard, Antoine
    Bidard, Francois-Clement
    Champion, Laurence
    Duong, Phuong
    Dercle, Laurent
    Seban, Romain-David
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (15)
  • [36] Affibode® molecules for molecular imaging of HER2-positive breast cancer lesions
    Hoiden-Guthenberg, I.
    Orlova, A.
    Tolmachev, V.
    Nilsson, F.
    Feldwisch, J.
    Wennborg, A.
    Baum, Richard P.
    EJC SUPPLEMENTS, 2007, 5 (08): : 25 - 25
  • [37] Optimizing the molecular design of 68Ga-labeled affibody molecules for in vivo PET imaging of HER3 expression
    Rinne, Sara
    Mitran, Bogdan
    Gentry, Joshua
    Vorobyeva, Anzhelika
    Leitao, Charles Dahlsson
    Andersson, Ken
    Lofblom, John
    Tolmachev, Vladimir
    Orlova, Anna
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2019, 62 : S468 - S470
  • [38] Using in vivo fluorescence lifetime imaging to detect HER2-positive tumors
    Ardeshirpour, Yasaman
    Sackett, Dan L.
    Knutson, Jay R.
    Gandjbakhche, Amir H.
    EJNMMI RESEARCH, 2018, 8
  • [39] Using in vivo fluorescence lifetime imaging to detect HER2-positive tumors
    Yasaman Ardeshirpour
    Dan L. Sackett
    Jay R. Knutson
    Amir H. Gandjbakhche
    EJNMMI Research, 8
  • [40] Affibody-Attached Hyperbranched Conjugated Polyelectrolyte for Targeted Fluorescence Imaging of HER2-Positive Cancer Cell
    Pu, Kan-Yi
    Shi, Jianbing
    Cai, Liping
    Li, Kai
    Liu, Bin
    BIOMACROMOLECULES, 2011, 12 (08) : 2966 - 2974
12345